Heart Metabolics' Series A - II Round

Heart Metabolics raised a round of funding on April 17, 2014.

Heart Metabolics is a biopharmaceutical company developing new treatments for cardio-metabolic diseases. The company's lead product candidate, perhexiline, has completed Phase 2 clinical trials as a t…

Articles about Heart Metabolics' Series A - II Round: